Marc Walther, President and CEO of Impact Fusion Files a Patent Pending Related to Artificial Insemination of Mammals

Rhea-AI Summary

Impact Fusion (OTCID: IFUS) announced that President and CEO Marc Walther filed a patent pending with the USPO on October 9, 2025 for an Artificial Insemination Technology (AIT™) for mammals. The company says AIT™ is available now, has been reviewed and approved by veterinarians, and is being tested on herds in the U.S.

The release cites market context: a global bovine AI market of USD 3.42 billion in 2025, North America at USD 930 million in 2024, and the U.S. market at USD 840 million in 2024. The company highlights potential cross-species applications and cost, genetic, and disease-control benefits.

Positive

• Patent pending filed on October 9, 2025
• Product reviewed and approved by veterinarians
• Active U.S. herd tests underway

Negative

• Commercial efficacy not yet proven—product is still in testing
• Claims rely on market forecasts (USD 3.42B market) not company sales figures

Napoleonville, Louisiana--(Newsfile Corp. - October 15, 2025) - Impact Fusion (OTCID: IFUS) announced today, that Marc Walther, President and CEO filed a Patent Pending on Thursday October 9, 2025 with the USPO related to the artificial insemination of mammals. Impact Fusion Artificial Insemination Technology™ (Impact Fusion AIT™) is available now. 

"I have long been aware of the importance of dairymen and cattle ranchers being able to have access to reliable, cost effective and safe artificial insemination of their heifers.

The size of the market in the USA alone, according to Precedence Research (Bovine Artificial Insemination Market Size to Hit USD 5.97 billion by 2034 (precedenceresearch.com) is currently valued at $3.42 billion USD in 2025. "The North America market (the largest market in the world) surpassed USD 930 million in 2024. The Asia Pacific market is expected to expand at the fastest CAGR of 7.3% during the forecast period."

According to Grand View Research (Bovine Artificial Insemination Market Size, Share Report 2030 (grandviewresearch.com)) the Indian government approved a plan to grant up to USD $5.99 to farmers for every bovine artificial insemination they undertake. They reached out to 2,500,000 cattle farmers with a budget of USD $44 million.

Over the past few years, it has been brought to my attention by cattle ranchers and dairymen, with whom I have worked while introducing our proprietary Bovine Ration Management Technology SGP+™, that the costs and challenges of propagating their herds naturally present added complexity to an already complex enterprise. I learned that often times in a financial necessity to up-breed the herd, a young heifer cannot support the weight of the bull during the breeding process. This causes undue suffering with fatal injuries to the heifer, while creating another level of financial burden on the operation. Furthermore, often times natural breeding is not effective. Our AIT™ process is designed to add to the success rate of AIP."

The use of Artificial Insemination (AI) is dramatically on the rise being considered a safer, cost effective and results oriented method of increasing herd size. In a report dated Aug 28, 2025, 60% of the US dairy cows are bred via AI. Conception rates vary between 50% and 76%. In Brazil conception rate as low as 55% up to 87.4% is reported of the 20% of all heifers bred via AI. That percentage is expected to increase in 2025. India reports the lowest conception rate across the country as 35% as compared to other countries that average 60% or higher. These are all target markets for Impact Fusion International for all of our products.

Tests are currently being conducted on herds in US. The protocols for implementation of the process have been well defined and will, in my opinion, create positive percentage increase in successful insemination's. The opportunities that exist, just in the USA alone, is aimed to have a dramatic impact on the breeding of mammals, not just cows but would include sheep, pigs, horses and potentially dog breeders and all mammals.

Market sizes for Bovine Artificial Insemination; Share and Trends 2025 to 2034

The global bovine artificial insemination market size is calculated at USD 3.42 billion in 2025 and is forecasted to reach around USD 5.97 billion by 2034, accelerating at a CAGR of 6.41% from 2025 to 2034. The North America market size surpassed USD 930 million in 2024 and is expanding at a CAGR of 6.58% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Bovine Artificial Insemination Market Key Takeaways

• North America dominated the bovine artificial insemination market with the largest share of 29% in 2024.
• Asia Pacific is expected to expand at the fastest CAGR of 7.3% during the forecast period.
• By solution, the service segment held the biggest market share of 40% in 2024.
• By solution, the semen segment is expected to witness the fastest growth during the projected timeframe.
• By distribution channel, the private segment contributed the biggest market share of 56% in 2024.
• By distribution channel, the public segment is projected to grow at a significant rate in the coming years.
• By sector, the dairy segment held the major market share of 64% in 2024.
• By sector, the meat segment is expected to grow at the fastest rate between 2025 and 2034.

Is Artificial Insemination Technology the Game Changer in Bovine Reproduction?

Artificial Insemination Technology (AIT™) is transforming bovine reproduction by enhancing efficiency, accuracy, and genetic advancements in breeding programs. High-merit bulls can be precisely selected with the help of machine learning models, increasing conception rates and reducing reproductive waste. Automation reduces human error and streamlines processes in herd management, embryo transfer, and semen sorting. Farmers can make data-driven breeding choices with real-time monitoring and sophisticated analytics, which ultimately increases the production of meat and dairy products. As AIT™ advances, the future of bovine reproduction is becoming more innovative, profitable, and sustainable.

U.S. Bovine Artificial Insemination Market Size and Growth 2025 to 2034

The U.S. bovine artificial insemination market size was exhibited at USD 840 million in 2024 and is projected to be worth around USD 1.590 million by 2034, growing at a CAGR of 6.60% from 2025 to 2034.

North America dominated the bovine artificial insemination market by capturing the largest share in 2024. This is mainly due to the high investments in precision breeding, widespread adoption of veterinary reproductive technologies, and increased demand for improved livestock genetics. The high consumption of dairy and beef products further bolstered the regional market growth. There is a strong focus on productivity improvement and sustainability in farming practices, which prompted partnerships between dairy cooperatives and genetic companies, solidifying North America's market leadership. Government-supported breeding initiatives and research facilities have also accelerated the development of disease-resistant cattle breeds and fertility management techniques. The region's market is expanding thanks to the growing trend of combining artificial insemination methods with digital herd management solutions.

The Asia Pacific bovine artificial insemination market is expected to expand at the fastest CAGR during the forecast period. This is mainly due to the rising government-sponsored genetic improvement initiatives, growing awareness among farmers about the benefits of artificial insemination, and rising demand for high-quality dairy products. China and India are making significant investments in breed improvement to increase meat quality and milk yield. Large-scale artificial insemination efforts are being supported by programs like the China Dairy Herd Genetic Improvement Plan and India's Rashtriya Gokul Mission. The rising adoption of genetic selection technologies among large-scale dairy cooperatives and the high focus on boosting milk production further contribute to regional market growth. Artificial insemination is also becoming more widespread in rural areas in the region due to government subsidies and farmer education programs.

Impact Fusion AIT™ is intended to support Best-Practice Economic Advantages like:

• Genetic Improvements by selecting mammals with higher herd uniformity and overall herd health.
• Cost Effective Processes that reduce purchasing and maintaining bulls, especially in large herds.
• Reproductive Efficiency with higher success percentage
• Disease Reduction in Herds, to include venereal disease.

"It is heart-rendering to hear from cattlemen and dairymen across the U.S. and Global community of the mounting struggles they are facing, while trying to supply food to all of us. With this in mind, I tasked members of our internal and external Scientific Team to focus on the impacts of our IFUS Product Lines so as to create a technology that can have a positive impact on IVF. Impact Fusion AIT™ is born from (1) requests from the market, (2) personal observations and experiences when I visit ranches and dairies, (3) reports of the positive impact IFUS Products and Technologies are having on birth-rates as well as the health and growth-rates of new-born calves, (4) increased colostrum and milk quality and quantity, and more," said Marc Walther, CEO of Impact Fusion International.

• Impact Fusion AIT™ is intended to join a family of products and technologies that provide real solutions that work in an eco-friendly, and cost-effective manner. Impact Fusion AIT™ has been reviewed and approved by veterinarians.

For more information Impact Fusion AIT™ call Marc Walther at 800-775-4130 or email at mwalther@impactfusionintl.com

www.impactfusionbrands.com/impact-fusion-artificial-insemination-process-for-mammals/

https://www.impactfusionbrands.com/product/ait-program-onboard-fee/

About Impact Fusion International Inc.

Impact Fusion International, Inc. is in the business of marketing products in the "Health and Wellness" sector of all international markets. It is the company's mission to invent, develop and market these proprietary products worldwide for the health and wellbeing of humans and animals. The information contained in this release includes some statement that are not purely historical and that are "forward-looking statements." Such forward-looking statements include, but are not limited to, statements regarding our and their management's expectations, hopes, beliefs, intentions or strategies regarding the future, including our financial condition, results of operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipates," "believes," "continue," "could," "estimates," "expects," "intends," "may," "might," "plans," "possible," "potential," "predicts," "projects," "seeks," "should," "would" and similar expressions, or the negatives of such terms, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this release are based on current expectations and beliefs concerning future developments and the potential effects on the parties and the corporate and administrative transactions. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements, even if new information becomes available in the future.

Contact: 
Impact Fusion International Inc. 
204 Highway 1011 
Napoleonville LA 70390 
1-800-775-4130
Email: marc@impactfusionintl.com
Website: www.impactfusionbrands.com
Twitter: @impactfusionI

#Impact Fusion AIT™ patent #Mammal AI breeding technology #Bovine AI conception rates #Dairy herd genetic enhancement #Beef cattle reproductive efficiency #North America's livestock AI market #Asia Pacific cattle breeding growth #India bovine AI subsidies #Brazil dairy AI adoption #U.S. cattle insemination innovation #Machine learning cattle breeding #Semen sorting for herd improvement #Biosecurity in mammal insemination #Cryopreservation livestock AI #Cost-effective dairy AI solutions #Venereal disease prevention cattle #SGP+™ supplement AI synergy #Sustainable bovine genetic selection #Genomic breeding for milk yield #Precision livestock fertility management

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270544

FAQ

What did Impact Fusion (IFUS) announce on October 15, 2025 about patents?

Impact Fusion announced CEO Marc Walther filed a patent pending with the USPO on October 9, 2025 for its Artificial Insemination Technology (AIT™).

Is Impact Fusion AIT™ available for use now (IFUS)?

The company states Impact Fusion AIT™ is available now and has been reviewed and approved by veterinarians, with tests ongoing in U.S. herds.

How large is the bovine artificial insemination market cited in the IFUS release?

The release cites a global bovine AI market of USD 3.42 billion in 2025, North America at USD 930 million in 2024, and the U.S. market at USD 840 million in 2024.

What species does Impact Fusion say AIT™ could address (IFUS)?

Impact Fusion describes potential application across mammals including cows, sheep, pigs, horses and possibly dogs.

Has Impact Fusion reported commercial results or sales for AIT™ (IFUS)?

No commercial sales figures are provided; the release notes tests are currently being conducted on herds in the U.S..

What benefits does Impact Fusion claim for AIT™ (IFUS)?

The company highlights genetic improvements, cost savings (fewer bulls), reproductive efficiency, and disease reduction as intended advantages.